2016
DOI: 10.1016/bs.seda.2016.08.026
|View full text |Cite
|
Sign up to set email alerts
|

Thyroid hormones, Iodine and Iodides, and Antithyroid Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 64 publications
0
1
0
Order By: Relevance
“…Prostate brachytherapy with 125 I sources is a choice for cancer patient treatment with early-stage prostate cancer. 125 I is used because of its low energy emissions, which allow for a rapid decrease in dose with distance, and of its short half-life (59.4 days) [7].…”
Section: Introduction mentioning
confidence: 99%
“…Prostate brachytherapy with 125 I sources is a choice for cancer patient treatment with early-stage prostate cancer. 125 I is used because of its low energy emissions, which allow for a rapid decrease in dose with distance, and of its short half-life (59.4 days) [7].…”
Section: Introduction mentioning
confidence: 99%